VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 355 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2013. The put-call ratio across all filers is 0.61 and the average weighting 1.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $14,487,000 | +103.6% | 910,000 | +1200.0% | 1.04% | +51.3% |
Q4 2015 | $7,116,000 | +33.0% | 70,000 | +133.3% | 0.69% | +47.8% |
Q3 2015 | $5,351,000 | -51.8% | 30,000 | -40.0% | 0.47% | -40.9% |
Q2 2015 | $11,107,000 | +51.8% | 50,000 | +35.7% | 0.79% | +35.3% |
Q1 2015 | $7,316,000 | -50.8% | 36,835 | -64.6% | 0.58% | -42.9% |
Q4 2014 | $14,883,000 | +8.0% | 104,000 | -1.0% | 1.02% | +7.5% |
Q3 2014 | $13,776,000 | -47.2% | 105,000 | -49.3% | 0.95% | -30.7% |
Q2 2014 | $26,107,000 | +204.7% | 207,000 | +218.5% | 1.37% | +315.1% |
Q1 2014 | $8,569,000 | +46.0% | 65,000 | +30.0% | 0.33% | +31.9% |
Q4 2013 | $5,870,000 | +60.7% | 50,000 | +42.9% | 0.25% | +37.2% |
Q3 2013 | $3,652,000 | -15.1% | 35,000 | -30.0% | 0.18% | -24.1% |
Q2 2013 | $4,304,000 | – | 50,000 | – | 0.24% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Brave Warrior Advisors | 6,586,582 | $864,160,000 | 32.02% |
FARLEY CAPITAL L.P. | 341,518 | $44,807,000 | 30.12% |
LeVasseur Capital Partners LLC | 190,404 | $24,981,000 | 29.94% |
Ruane, Cunniff & Goldfarb | 34,494,015 | $4,525,615,000 | 23.97% |
ValueAct Holdings | 18,923,877 | $2,482,813,000 | 16.64% |
White River Investment Partners, LLC | 90,099 | $11,820,000 | 16.35% |
Tesuji Partners | 1,368,040 | $179,487,000 | 15.45% |
Arrow Capital Management, LLC | 197,500 | $25,912,000 | 15.11% |
Hound Partners | 3,576,998 | $469,302,000 | 14.87% |
Brahman Capital Corp. | 4,457,153 | $584,778,000 | 12.82% |